XTRESSE, LLC

SEC filing

Pharmaceuticals · Orlando, FL

Form D on EDGAR

Amount raised$2.7Msold at filing

Total offering$10M$7.3M still open

Investors in the raise30count reported to the SEC

FiledNov 24, 2025first sale Oct 24, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Matt LeavittDirector

Executive officers, directors and promoters as listed on the Form D.